Eqis Capital Management Inc. Trims Stake in Humana Inc (NYSE:HUM)

Eqis Capital Management Inc. Trims Stake in Humana Inc (NYSE:HUM)

Eqis Capital Management Inc. lessened its holdings in Humana Inc (NYSE:HUM) by 26.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,688 shares of the insurance provider’s stock after selling 2,453 shares during the period. Eqis Capital Management Inc.’s holdings in Humana were worth $1,916,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the company. FMR LLC lifted its stake in shares of Humana by 1.4% in the 3rd quarter. FMR LLC now owns 12,379,797 shares of the insurance provider’s stock worth $4,190,809,000 after purchasing an additional 167,283 shares during the period. BlackRock Inc. lifted its stake in shares of Humana by 1.2% in the 3rd quarter. BlackRock Inc. now owns 12,311,736 shares of the insurance provider’s stock worth $4,167,767,000 after purchasing an additional 140,731 shares during the period. Vanguard Group Inc lifted its stake in shares of Humana by 1.4% in the 3rd quarter. Vanguard Group Inc now owns 10,104,225 shares of the insurance provider’s stock worth $3,420,482,000 after purchasing an additional 140,864 shares during the period. Capital International Investors lifted its stake in shares of Humana by 3,030.3% in the 3rd quarter. Capital International Investors now owns 8,217,296 shares of the insurance provider’s stock worth $2,781,719,000 after purchasing an additional 7,954,786 shares during the period. Finally, Renaissance Technologies LLC lifted its stake in shares of Humana by 14.1% in the 3rd quarter. Renaissance Technologies LLC now owns 3,174,800 shares of the insurance provider’s stock worth $1,074,733,000 after purchasing an additional 391,300 shares during the period. Hedge funds and other institutional investors own 92.51% of the company’s stock.

A number of equities research analysts have commented on HUM shares. raised their target price on shares of Humana from $350.00 to $373.00 and gave the stock an “outperform” rating in a research note on Thursday, November 8th. Jefferies Financial Group raised their target price on shares of Humana from $388.00 to $410.00 and gave the stock a “buy” rating in a research note on Thursday, November 8th. Bank of America raised their target price on shares of Humana from $400.00 to $415.00 and gave the stock a “buy” rating in a research note on Thursday, November 8th. Credit Suisse Group raised their target price on shares of Humana from $370.00 to $390.00 and gave the stock an “outperform” rating in a research note on Thursday, November 8th. Finally, Royal Bank of Canada raised their target price on shares of Humana from $318.00 to $349.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 8th. Five analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Humana currently has an average rating of “Buy” and an average price target of $355.06.

Shares of HUM stock opened at $298.89 on Friday. Humana Inc has a 12-month low of $261.13 and a 12-month high of $355.88. The firm has a market capitalization of $41.70 billion, a PE ratio of 20.54, a PEG ratio of 1.19 and a beta of 1.05. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.68 and a quick ratio of 1.68.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, February 6th. The insurance provider reported $2.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.12. The company had revenue of $14.17 billion during the quarter, compared to analyst estimates of $14.04 billion. Humana had a net margin of 2.96% and a return on equity of 19.64%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.06 EPS. Equities analysts expect that Humana Inc will post 17.48 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 26th. Investors of record on Friday, March 29th will be paid a $0.55 dividend. The ex-dividend date is Thursday, March 28th. This is a positive change from Humana’s previous quarterly dividend of $0.50. This represents a $2.20 dividend on an annualized basis and a yield of 0.74%. Humana’s dividend payout ratio is presently 6.87%.

In other Humana news, insider Heidi S. Margulis sold 2,656 shares of the business’s stock in a transaction dated Tuesday, December 18th. The shares were sold at an average price of $296.22, for a total transaction of $786,760.32. Following the sale, the insider now directly owns 10,371 shares of the company’s stock, valued at approximately $3,072,097.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director David A. Jr/Ky Jones sold 600 shares of the company’s stock in a transaction dated Friday, November 16th. The shares were sold at an average price of $88.05, for a total transaction of $52,830.00. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by corporate insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts.

Recommended Story: Understanding each part of a balance sheet

Related posts

Leave a Comment